Upgrade to SI Premium - Free Trial

Agilent Technologies (A) Granted Approval for First PD-L1 Companion Diagnostic in China

October 2, 2019 10:44 AM
Agilent Technologies Inc. (NYSE: A) today announced that the National Medical Products Administration (NMPA, formerly the China Food and Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles